Perseus Proteomics Inc. (TYO:4882)
Japan
· Delayed Price · Currency is JPY 218.00
+3.00 (1.40%)
Apr 28, 2026, 3:30 PM JST
Perseus Proteomics Market Cap
Perseus Proteomics has a market cap or net worth of 3.28 billion as of April 29, 2026. Its market cap has decreased by -51.61% in one year.
Market Cap
3.28B
Enterprise Value
2.05B
Revenue
140.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
218.00
Market Cap Chart
Since June 22, 2021, Perseus Proteomics's market cap has decreased from 10.12B to 3.28B, a decrease of -67.58%. That is a compound annual growth rate of -20.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 3.28B | -0.70% |
| Dec 30, 2025 | 3.30B | -60.12% |
| Dec 30, 2024 | 8.28B | 13.70% |
| Dec 29, 2023 | 7.29B | 97.33% |
| Dec 30, 2022 | 3.69B | -20.91% |
| Dec 30, 2021 | 4.67B | -53.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| JCR Pharmaceuticals | 68.07B |
| Santen Pharmaceutical | 529.97B |
| Ono Pharmaceutical | 1,104.28B |
| Kyowa Kirin | 1,213.71B |
| Astellas Pharma | 4,273.41B |
| Daiichi Sankyo Company | 4,772.46B |
| Otsuka Holdings | 5,613.31B |
| Chugai Pharmaceutical | 12.25T |